Dr. Michael Schlossmacher holds the Bhargava Family Research Chair in Neurodegeneration at The Ottawa Hospital and is a professor at the University of Ottawa. He obtained his MD degree in Vienna before moving to Harvard Medical School, where he carried out postdoctoral studies on the pathogenesis of Alzheimer’s and completed his neurology residency training and a fellowship in movement disorders. In Canada, he has developed a multi-disciplinary research program in Parkinson’s disease (PD). He focuses on exploring environment-gene interactions in brain health with an emphasis on the olfactory route, parkin’s role in protecting dopamine neurons and developing an algorithm to quantify PD risk that includes a simplified, self-administered smell test (NeuroScent Card). His patented discoveries on the GBA1-SNCA link helped launch two clinical trials in PD. In his clinical activities and as co-director of the Parkinson’s Research Consortium Ottawa, Dr. Schlossmacher supports people with PD and their families and encourages patient advocacy.